Elite Trades From Anywhere

$100 Off Your First Year

Claim Now
Category
Global or ExUS Equities - Industry Sector
Sponsor
Van Eck Associates Corporation
Fund Family
Index
MVIS US Listed Pharmaceutical 25 Index
Index Weighting
Active/Passive
Expense
0.36%
Inverse/Leveraged
IPO
Dec 21, 2011
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / Yes
Tags
Tags
Tags
Tags
Tags
-
Tags
-
Tags
-
Sector/Theme
Region
SMA20
5.00%
SMA50
6.91%
SMA200
8.98%
Return% 1Y
27.66%
Return% 3Y
13.90%
Return% 5Y
10.69%
Return% 10Y
Return% SI
Flows% 1M
-6.25%
Flows% 3M
-30.76%
Flows% YTD
-29.92%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
26
AUM
930.81M
NAV/sh
52W High
112.58 -1.89%
52W Low
81.74 35.12%
Volatility
1.54% 1.54%
ATR (14)
1.78
RSI (14)
67.47
Beta
0.44
Rel Volume
3.26
Avg Volume
268.89K
Volume
876,759
Perf Week
6.75%
Perf Month
4.48%
Perf Quarter
9.39%
Perf Half Y
5.90%
Perf YTD
7.06%
Perf Year
26.27%
Perf 3Y
41.55%
Perf 5Y
50.74%
Perf 10Y
90.04%
Prev Close
109.44
Price
110.45
Change
0.92%
Mar-30-26 10:44AM
Feb-18-26 01:05PM
Feb-04-26 09:30AM
Jan-28-26 06:20AM
Jan-23-26 10:36AM
02:30AM Loading…
Jan-16-26 02:30AM
Jan-02-26 09:51AM
Dec-29-25 08:46AM
Dec-19-25 12:15PM
Dec-09-25 01:40PM
Nov-27-25 06:20AM
Nov-24-25 07:00AM
Nov-14-25 07:59AM
Nov-10-25 07:47AM
Oct-16-25 03:14AM
06:10AM Loading…
Oct-13-25 06:10AM
Oct-10-25 06:09PM
Oct-06-25 06:57AM
Oct-01-25 11:10AM
Sep-26-25 01:05PM
09:24AM
Sep-22-25 06:20AM
Aug-19-25 06:15AM
Aug-08-25 11:00AM
Jul-22-25 06:20AM
Jul-17-25 11:00AM
Jul-01-25 06:20AM
Jun-18-25 06:20AM
May-21-25 06:20AM
May-15-25 10:00AM
08:00AM Loading…
May-13-25 08:00AM
May-12-25 12:52PM
10:30AM
May-09-25 06:20AM
May-08-25 11:50AM
May-02-25 03:25AM
Apr-30-25 04:35AM
Apr-28-25 06:20AM
Apr-23-25 05:45AM
Apr-18-25 01:40PM
Apr-17-25 06:20AM
Apr-16-25 10:00AM
Apr-14-25 09:15AM
Apr-04-25 08:30AM
Apr-02-25 07:00AM
Apr-01-25 05:40AM
Mar-29-25 12:50AM
Mar-28-25 06:05AM
Mar-20-25 04:32PM
06:20AM
Dec-20-24 08:56PM
Sep-20-22 03:13PM
Mar-26-22 10:00PM
Jan-24-22 01:38PM
Dec-14-21 10:38PM
May-22-20 07:46AM
May-18-20 10:03AM
Apr-09-20 10:10AM
Feb-07-20 11:05AM
Jan-22-20 01:00PM
Dec-20-19 08:10AM
Dec-05-19 03:34PM
Nov-22-19 05:15PM
Nov-08-19 08:00AM
Nov-06-19 11:00AM
Sep-30-19 06:04PM
Sep-23-19 11:27AM
Sep-09-19 02:09PM
Aug-22-19 11:12AM
Aug-07-19 10:59AM
Jun-28-19 06:01PM
Jun-26-19 11:00AM
Jun-25-19 06:01PM
May-14-19 05:40PM
May-09-19 10:05AM
Apr-30-19 12:59PM
Mar-29-19 06:42PM
Mar-21-19 07:56AM
Feb-21-19 10:08AM
Feb-07-19 11:15AM
Jan-29-19 09:08AM
Jan-07-19 09:27AM
Dec-26-18 06:37PM
Dec-14-18 09:28AM
Dec-10-18 10:33AM
Nov-16-18 05:52PM
Oct-24-18 11:59AM
Oct-17-18 11:48AM
Oct-12-18 06:00AM
Oct-09-18 11:39AM
Sep-28-18 06:03PM
Jul-03-18 03:19PM
Jun-29-18 06:15PM
Jun-04-18 10:38AM
Apr-24-18 06:41AM
Mar-29-18 05:58PM
Jan-25-18 09:00AM
07:31AM
Jan-22-18 10:00AM
07:34AM
VanEck Pharmaceutical ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.